AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F108. A total of 78 filers reported holding AVALO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $60,000 | – | 27,507 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 45,000,000 | $76,500,000 | 1.25% |
| Stonepine Capital Management, LLC | 1,510,095 | $2,567,000 | 1.18% |
| Integral Health Asset Management, LLC | 1,625,000 | $2,763,000 | 0.76% |
| Opaleye Management Inc. | 1,459,400 | $2,481,000 | 0.53% |
| Nantahala Capital Management | 7,145,874 | $12,148,000 | 0.43% |
| Ikarian Capital, LLC | 718,705 | $1,223,000 | 0.18% |
| Soleus Capital Management, L.P. | 770,000 | $1,309,000 | 0.13% |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,198,757 | $2,038,000 | 0.05% |
| Point72 Asset Management, L.P. | 6,008,850 | $10,215,000 | 0.04% |
| Minot Wealth Management LLC | 34,645 | $59,000 | 0.01% |